PKP2 induced by YAP/TEAD4 promotes malignant progression of gastric cancer
Molecular Carcinogenesis · 2024
DOI: 10.1002/mc.23751 ↗At a glance
Journal article in Molecular Carcinogenesis, 2024. Written by Yunyun Liu and 7 co-authors. Institution: Research Center of Basic Medicine, Jinan Central Hospital, Shandong University, Jinan, China. Major MEDLINE topics: Stomach Neoplasms, Transcription Factors, Plakophilins, TEA Domain Transcription Factors. Cited 4 times so far (Crossref); 54 references. Funded by: National Natural Science Foundation of China, Shandong Provincial Natural Science Foundation of China.
Abstract (original language)
Gastric cancer (GC) exhibits significant heterogeneity and its prognosis remains dismal. Therefore, it is essential to investigate new approaches for diagnosing and treating GC. Desmosome proteins are crucial for the advancement and growth of cancer. Plakophilin‐2 (PKP2), a member of the desmosome protein family, frequently exhibits aberrant expression and is strongly associated with many tumor types’ progression. In this study, we found upregulation of PKP2 in GC. Further correlation analysis showed a notable association between increased PKP2 expression and both tumor stage and poor prognosis in individuals diagnosed with gastric adenocarcinoma. In addition, our research revealed that the Yes‐associated protein1 (YAP1)/TEAD4 complex could stimulate the transcriptional expression of PKP2 in GC. Elevated PKP2 levels facilitate activation of the AKT/mammalian target of rapamycin signaling pathway, thereby promoting the malignant progression of GC. By constructing a mouse model, we ultimately validated the molecular mechanism and function of PKP2 in GC. Taken together, these discoveries suggest that PKP2, as a direct gene target of YAP/TEAD4 regulation, has the potential to be used as an indication of GC progression and prognosis. PKP2 is expected to be a promising therapeutic target for GC.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Research Center of Basic Medicine, Jinan Central Hospital, Shandong University, Jinan, China.
- Research Center of Basic Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
- Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
ORCID profiles: Yanfei Jia
Funding
- National Natural Science Foundation of China
- Shandong Provincial Natural Science Foundation of China
Cite
APA
Liu, Y., Lu, Y., Xing, Y., Zhu, W., Liu, D., Ma, X., Wang, Y., & Jia, Y. (2024). PKP2 induced by YAP/TEAD4 promotes malignant progression of gastric cancer. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23751
Vancouver
Liu Y, Lu Y, Xing Y, Zhu W, Liu D, Ma X, et al. PKP2 induced by YAP/TEAD4 promotes malignant progression of gastric cancer. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23751
BibTeX
@article{Liu2024,
author = {Liu, Yunyun and Lu, Yi and Xing, Yuanxin and Zhu, Wenshuai and Liu, Duanrui and Ma, Xiaoli and Wang, Yunshan and Jia, Yanfei},
title = {PKP2 induced by YAP/TEAD4 promotes malignant progression of gastric cancer},
journal = {Molecular Carcinogenesis},
year = {2024},
doi = {10.1002/mc.23751}
}
EUVIMED